TD Cowen lowered the firm’s price target on Procter & Gamble to $175 from $189 and keeps a Buy rating on the shares. The firm noted they reported a slight Q3 sales miss and lowered sales and EPS guidance for FY25 to reflect weaker consumer confidence particularly in U.S., and 3-5c of tariff costs in 4Q.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $175 from $185 at Wells Fargo
- Procter & Gamble: Long-Term Growth Potential Amid Short-Term Challenges Justifies Buy Rating
- Procter & Gamble price target lowered to $181 from $200 at Citi
- Procter & Gamble price target lowered to $180 from $190 at BofA
- Procter & Gamble upgraded to Outperform from Sector Perform at RBC Capital